Efficacy and tolerability of a new formulation of oral tiludronate (tablet) in the treatment of Paget's disease of bone

Journal article

Peer reviewed

J. Y Reginster, R Treves, J. C Renier, B Amor, J Sany, D Ethgen, C Picot and P Franchimont

Journal of bone and mineral research, Vol.9(5), pp.615-619

05/1994

PMID: 8053389

Abstract

Biological and medical sciences

Bones, joints and connective tissue. Antiinflammatory agents

Medical sciences

Pharmacology. Drug treatments

1 Record Views

Title: Efficacy and tolerability of a new formulation of oral tiludronate (tablet) in the treatment of Paget's disease of bone
Creators - without role: J. Y Reginster - University of Liège
R Treves - Hôpital Dupuytren
J. C Renier - Centre Hospitalier Universitaire d'Angers
B Amor - Hôpital Cochin
J Sany - Hôpital Gui de Chauliac
D Ethgen - Sanofi
C Picot - Sanofi
P Franchimont - University of Liège
Publication Details: Journal of bone and mineral research, Vol.9(5), pp.615-619
Publisher: American Society for Bone and Mineral Research
Identifiers: 9952615708331
Academic Unit: King Saud University
Language: English
Resource Type: Journal article